SCHEMBL29960352

SCHEMBL29960352

CCOC(=O)CC(C[N+](=O)[O-])c1sccc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 3/20 0.37
VCP P55072 1/20 0.35
PKM P14618 1/20 0.34
HPGD P15428 3/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 2/20 0.34
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TNF P01375 1/20 0.33
NPC1 O15118 1/20 0.33
S1PR4 O95977 1/20 0.33
ITGA4 P13612 1/20 0.33
S1PR1 P21453 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960831 0.79 ALDH1A1 (0.36) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL6480926 0.79 ALOX5 (0.37) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL29960727 0.77 PKM (0.39) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL29960595 0.76 ALDH1A1 (0.38) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL19860132 0.76 ALDH1A1 (0.39) ALDH1A1LMNAMAPTKDM4EPKM
SCHEMBL1269160 0.75 ALOX15 (0.46) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL6556296 0.75 ALDH1A1 (0.44) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL29219309 0.74 ALDH1A1 (0.39) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL2040186 0.74 KDM4E (0.42) ALDH1A1CYP2C19LMNAMAPTKDM4E
SCHEMBL6492480 0.74 ALDH1A1 (0.35) ALDH1A1CYP2C19LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed